|
|
|
Volumn 2, Issue 1, 2001, Pages 18-21
|
|
Primary angioplasty and the increasing number of catheterization laboratories
|
|
Author keywords
Acute myocardial infarction; Primary angioplasty
|
|
Indexed keywords
FIBRINOLYTIC AGENT;
ACUTE HEART INFARCTION;
ANGIOPLASTY;
ARTICLE;
CHEMOTHERAPY;
CLINICAL LABORATORY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY CARE UNIT;
CORONARY REPERFUSION;
COST EFFECTIVENESS ANALYSIS;
FIBRINOLYTIC THERAPY;
HEALTH SURVEY;
HEART CATHETERIZATION;
HEART MUSCLE ISCHEMIA;
HEART REINFARCTION;
HUMAN;
INCIDENCE;
INTERMETHOD COMPARISON;
MAJOR CLINICAL STUDY;
MEDICAL TECHNOLOGY;
MORTALITY;
PATIENT REFERRAL;
PATIENT TRANSPORT;
RANDOMIZED CONTROLLED TRIAL;
RECURRENT DISEASE;
REGIONALIZATION;
STATISTICAL MODEL;
TREATMENT INDICATION;
COST;
ECONOMICS;
HEART INFARCTION;
HEMODYNAMICS;
ITALY;
LABORATORY;
REGISTER;
STATISTICS;
UNITED STATES;
ANGIOPLASTY;
CLINICAL TRIALS;
COSTS AND COST ANALYSIS;
HEMODYNAMIC PROCESSES;
HUMANS;
ITALY;
LABORATORIES;
MYOCARDIAL INFARCTION;
REGISTRIES;
UNITED STATES;
|
|
EID: 0035112591
PISSN: 11294728
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (15)
|
